Literature DB >> 12895452

Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease.

Michelangelo Mancuso1, Massimiliano Filosto, Francesca Bosetti, Roberto Ceravolo, Anna Rocchi, Gloria Tognoni, Maria Laura Manca, Giancarlo Solaini, Gabriele Siciliano, Luigi Murri.   

Abstract

Increasing evidence indicates that mitochondrial dysfunction occurs in the central nervous system as well as in the peripheral tissues from Alzheimer's disease (AD) patients. We have recently shown that mitochondrial cytochrome c oxidase (COX) activity is significantly reduced in brain and platelets from AD patients compared to controls. In the present study we investigated whether impaired COX activity could have functional consequences on energy metabolism. Blood lactate concentration was monitored at rest and during incremental exercise in 22 AD patients in whom COX activity in platelets was decreased compared to controls (35.7 +/- 11.4 vs 48.4 +/- 1.4 nmol/min/mg, P < 0.01). In both resting and exercising conditions, blood lactate was significantly higher in AD patients than in controls. Although the magnitude of exercise-related lactate accumulation was not different between the two groups, an anticipated anaerobic lactate threshold during the incremental forearm exercise was found in AD patients (50% of maximal voluntary contraction MVC compared to 60% in controls). COX activity was inversely related to lactate at a significant level for resting condition (r = -0.65) and borderline for anaerobic threshold exercise level. These results support the hypothesis of a systemic impairment of the mitochondrial function in AD and indicate that decreased COX activity could have functional consequences on metabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12895452     DOI: 10.1016/s0014-4886(03)00092-x

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  26 in total

1.  Cardiorespiratory response to exercise testing in individuals with Alzheimer's disease.

Authors:  Sandra A Billinger; Eric D Vidoni; Robyn A Honea; Jeffrey M Burns
Journal:  Arch Phys Med Rehabil       Date:  2011-12       Impact factor: 3.966

Review 2.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

3.  Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation.

Authors:  Katalin Völgyi; Krisztina Háden; Viktor Kis; Péter Gulyássy; Kata Badics; Balázs András Györffy; Attila Simor; Zoltán Szabó; Tamás Janáky; László Drahos; Árpád Dobolyi; Botond Penke; Gábor Juhász; Katalin Adrienna Kékesi
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

Review 4.  Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.

Authors:  Kristina Leuner; Kathrin Schulz; Tanja Schütt; Johannes Pantel; David Prvulovic; Virginie Rhein; Egemen Savaskan; Christian Czech; Anne Eckert; Walter E Müller
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

5.  Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction.

Authors:  Xueqi Gan; Long Wu; Shengbin Huang; Changjia Zhong; Honglian Shi; Guangyue Li; Haiyang Yu; Russell Howard Swerdlow; John Xi Chen; Shirley ShiDu Yan
Journal:  Free Radic Biol Med       Date:  2014-07-23       Impact factor: 7.376

6.  Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release.

Authors:  A M Aleardi; G Benard; O Augereau; M Malgat; J C Talbot; J P Mazat; T Letellier; J Dachary-Prigent; G C Solaini; R Rossignol
Journal:  J Bioenerg Biomembr       Date:  2005-08       Impact factor: 2.945

Review 7.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

Review 8.  Mitochondria, Cybrids, Aging, and Alzheimer's Disease.

Authors:  R H Swerdlow; S Koppel; I Weidling; C Hayley; Y Ji; H M Wilkins
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-01       Impact factor: 3.622

9.  Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.

Authors:  Antonella Bobba; Vito A Petragallo; Ersilia Marra; Anna Atlante
Journal:  Int J Alzheimers Dis       Date:  2010-09-02

Review 10.  Amyloid precursor protein processing and bioenergetics.

Authors:  Heather M Wilkins; Russell H Swerdlow
Journal:  Brain Res Bull       Date:  2016-08-18       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.